1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D14CBFE6A505E5988525774A00622076
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/government-affairs-public-policy-groups-optimize-structures-and-operational-resources?opendocument
18
19opendocument
2044.210.149.218
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » »

Government Affairs & Public Policy Excellence: Optimizing Group Structure & Operations

ID: PSM-252


Features:

14 Info Graphics

27 Data Graphics

151 Metrics

28 Narratives


Pages: 72


Published: Pre-2019


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Businesses today face tougher regulations and scrutiny, which necessitates strong Government Affairs and Public Policy groups that can direct and oversee complex matters in regards to public policy and legislation. Government Affairs and Public Policy can ensure movement from a reactive to a proactive to a anticipatory stance with many of these outside organizations.

For Government Affairs and Public Policy to be effective, those leading the groups must be connected to their organization’s goals and corporate leadership -- which can be an ongoing and challenging process.

Best Practices, LLC conducted research to identify the functional factors that drive Government Affairs and Public Policy to better support the entire business operation.

Also, this study presents different organizational models for pharma Government Affairs and Public Policy groups and current trends in staffing and budgets for these groups as well.

Government Affairs and Public Policy leaders can use this research to compare their organizational structure and resourcing with those of leading organizations.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Medical Device


Companies Profiled:
Abbott; DRI; Novo Nordisk; Biomarin; Genentech; AstraZeneca; Boehringer Ingelheim; Roche; UCB Pharma; GlaxoSmithKline; Solvay Pharmaceuticals; Stiefel; Pfizer; Lilly; Baxter International; Cephalon; Inc.

Study Snapshot

This benchmarking research included 16 Government Affairs and Public Policy executives and managers at 15 leading bio-pharmaceutical, healthcare and medical device companies.

Benchmark partners reflect functional experience that interacts directly or indirectly with the Government Affairs function. Because Government Affairs resides in different places across different companies, diverse functions from Government Affairs, Federal Affairs, Communications, Medical Affairs and Public Policy participated in this study.

Field interviews and study analysis produced many observations and benchmark findings. Key study insights reflect the inter-related evolution of a company’s commercial structure and how Government Affairs is organized to serve internal and external customers.

Sample Key Findings

Differentiated Services Are the Norm for Government Affairs: Almost three-quarters of participants said they vary the level of services – staffing, time, and responsiveness – across internal customers. The practice reflects the significant impact that Government Affairs can have on important business issues such as reimbursement and regulatory. It further underscores how small expert staffs provide services to diverse stakeholders while reflecting differences in stakeholder issues and impact.

  • Outsourcing Is an Emerging Staffing Tactic for Government Affairs in the U.S. Market: Outsourcing of Government Affairs staff is a viable staffing strategy in the U.S. marketplace but is less utilized outside U.S. markets. The maximum outsourced Government Affairs staff in the U.S. reached 51% at one benchmark company. Still others don’t outsource. The average mix is about 70% in-sourced and 30% outsourced in the U.S. Expanded outsourcing strategies are another approach to managing with reduced staffing resources.
Table of Contents

Project Blueprint
  • Executive Summary: Benchmark Insights and Research Group
  • Government Affairs Group Structures: Key Trends & Drivers of Sub-group Evolution
  • Government Affairs Group Models and Structures
  • Government Affairs & Policy Groups Staffing Benchmarks: Key Trends in Resourcing Government Affairs Groups
  • Government Affairs & Policy Funding Levels & Sources: Examining the Resources Invested for Success
  • Government Affairs & Policy Group Services: Trends in Service Levels & Key Priorities
  • Government Affairs & Policy Responsibilities: Trends in Forging Accountability & Clear Roles
  • Communicating the Value of Government Affairs & Policy In a Global Bio-Pharma Company
  • Contact Information